<article id="sc_page01" class="slide" data-ag-slide-name="sc_page01">
    <div class="basic">
      <h1 data-ag-editable="Main Title">Neulasta<sup>®</sup> is predominantly cleared by
          neutrophils<sup>[SmPC] [Molineux 2003]</sup></h1>
        <!-- Content here -->
        <div id="center-content">
            <h4 data-ag-editable="Subtitle">Neulasta<sup>®</sup> delivers sustained activity due to reduced renal clearance<sup>[Molineux 2003] </sup></h4>
            <div id ="gray-box">
                <div id="first-image"></div>
                <div id="first-desc" data-ag-editable="First Desc"><p>Neulasta<sup>®</sup> is pegylated filgrastim<sup>[SmPC]</sup></p>
                   <p> Polyethylene glycol (PEG) molecule </br> attached to N-terminus of filgrastim<sup>[Molineux 2003]</sup> </p>
                </div>
                <div id="big-arrow"> </div>
                <div id="second-image"> </div>
                <div class="second-desc" data-ag-editable="Second Disc"><p>Neulasta<sup>®</sup> is mainly eliminated by neutrophil-mediated clearance<sup>[SmPC]</sup></p></div>
                <div id="small-arrow"> </div>
                <div id="third-image"> </div>
                <div class="second-desc" id="third-desc"><p data-ag-editable="Third Disc">Neulasta<sup>®</sup> has reduced renal clearance<sup>[SmPC]</sup></p></div>

            </div>
        </div>
        <div id="footer"><p>Neulasta<sup>®</sup> remains present until neutrophil recovery, after which it is effectively cleared </br> by the neutrophils<sup>[Molineux 2003]</sup></p></div>
    </div>
    <!-- Reference Information Starts -->
    <div class="lightbox_data" id="sc_page01_refs">
       <div class="main_content_style">
          <p><strong data-ag-editable="References Title">References:</strong></p>
          <br />
          <div data-ag-editable="References List">
             <ol>
                 <li>Neulasta<sup>®</sup>, Summary of Product Characteristics</li>
                 <li>Molineux G. Pegfilgrastim: using pegylation technology to improve neutropenia support in cancer patients. Anticancer Drugs 2003; 14(4):259-264
                 </li>
             </ol>
          </div>
          <p id="copy-bottom" data-ag-editable="References Bottom Copy"> Date of preparation: January 2014</br>
              Job code: NO-IHQ-AMG-040-2014 January</p>
       </div>
    </div>
    <!-- Reference Information Ends -->
</article>